Amrita, Wipro win award for novel diabetes solution

 Amrita Vishwa Vidyapeetham and IT major Wipro have jointly won the Aegis Graham Bell Award 2017 in the ‘Innovation in mHealth’ category for a first-of-its-kind and cost-effective diabetes

Published: 05th March 2018 09:50 PM  |   Last Updated: 06th March 2018 04:50 AM   |  A+A-

By Express News Service

KOCHI: Amrita Vishwa Vidyapeetham and IT major Wipro have jointly won the Aegis Graham Bell Award 2017 in the ‘Innovation in mHealth’ category for a first-of-its-kind and cost-effective diabetes management solution they jointly developed. The Graham Bell Award is among one of the world’s topmost technology awards to honour innovation in IT and communications.The end-to-end mobile health solution for diabetics uses a novel insulin pump and glucose-monitoring system, integrated with a cloud-based monitoring app for more efficient and effective diabetes care.

The Amrita-Wipro team after receiving the
Aegis Graham Bell Award

The project is supported by the Biotechnology Industry Research Assistance Council (BIRAC) of the Government of India. This diabetes management solution enables patient compliance and significantly improve the quality of life at a very low cost, even for patients living in the remotest areas of the country.
“The development of this novel diabetes management solution underscores the potential of what can be achieved in the healthcare sector through unique partnerships,” said Dr Bipin Nair, dean of Amrita School of Biotechnology, Amrita Vishwa Vidyapeetham.

“We are grateful for the support provided by BIRAC. We are delighted to be recognised for our efforts to address the growing issue of diabetes in India and help patients avail treatment at an affordable cost. Diabetes cannot be cured, only managed. We have developed two affordable devices to better manage diabetes: an automated insulin pump and a glucose-monitoring system.”

Wipro, which is working on making both the devices Bluetooth-capable, has already developed an easy-to-use mobile app for these devices. Patient data from the devices will be transferred by the app to a digital backbone that includes a dedicated server and cloud. These, in turn, will be connected round-the-clock with a diabetes helpline, endocrinologists, NGOs, the patient’s family and so on.The project team led by Dr Bipin Nair included researchers from Amrita Vishwa Vidyapeetham’s Coimbatore campus Satheesh Babu, John Stanley and K Guruvayurappan, as well as Dr Harish Kumar and the team from the Endocrinology Department of Amrita Institute of Medical Sciences.


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

  • Abhijt

    3 years ago reply
flipboard facebook twitter whatsapp